Intravitreal injection versus medical treatment for acute CSR
Phase 3
- Conditions
- Eye Diseases
- Registration Number
- PACTR202204601902304
- Lead Sponsor
- Suez Canal University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Patients older than 18 years old, with presence of serous detachment of neurosensory retina on optical coherence tomography angiography (OCTA), evidence of fluorescent leakage on fundus fluorescein angiography (FFA) and symptom duration less than 3 months will be enrolled in the study.
Exclusion Criteria
Patients with chronic CSCR, secondary choroidal neovascularization, other eye diseases such as AMD, polypoidal choroidal vasculopathy, glaucoma, or ocular trauma; or having history of systemic steroid usage before the onset of the clinical symptoms will be excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual recovery
- Secondary Outcome Measures
Name Time Method Central macular thickness, central choroidal thickness, vascular density, pattern on flourescein angiography and duration of visual recovery